Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan:96:23-25.
doi: 10.1016/j.jsat.2018.10.007. Epub 2018 Oct 17.

Fentanyl exposure among patients seeking opioid treatment

Taylor A Ochalek  1 , Maria A Parker  2 , Stephen T Higgins  3 , Stacey C Sigmon  3
Affiliations

Fentanyl exposure among patients seeking opioid treatment

Taylor A Ochalek et al. J Subst Abuse Treat. 2019 Jan.

Abstract

Aim: Overdoses attributed to the potent opioid agonist fentanyl have substantially increased in recent years. Despite these serious public health consequences, many opioid treatment providers do not currently include a fentanyl assay in their urine toxicology testing. As a result, extent of fentanyl exposure and related risks among individuals with opioid use disorder often remains unknown. We examined the prevalence of fentanyl exposure among patients seeking or enrolled in opioid agonist treatment.

Methods: Six hundred urine specimens were collected from adults entering (n = 100) or enrolled in (n = 500) opioid agonist treatment and analyzed using the clinic's standard opioid panel, supplemented with a 100 ng/ml fentanyl assay.

Results: Of the 100 specimens collected from patients at treatment intake, 19 (19%) tested positive for fentanyl. Importantly, 17 (90%) of those fentanyl-positive specimens were also positive for heroin. Of the 500 collected from patients in treatment, 17 (3%) of specimens tested positive for fentanyl. Of those, 11 (92%) were also positive for heroin.

Conclusion: These data illustrate a concerning degree of fentanyl exposure among patients seeking treatment and suggest that much of this exposure may have stemmed from fentanyl-containing heroin. Given the unprecedented recent surges in fentanyl-related overdoses, efforts to identify fentanyl exposure are critical. In particular, the point of treatment entry permits a rare systematic opportunity for medical and clinical staff to address fentanyl use and risks with incoming patients.

Keywords: Agonist maintenance; Buprenorphine; Fentanyl; Methadone; Opioid use disorder; Overdose.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest disclosure: The authors have no conflicts to declare.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Amlani A, McKee G, Khamis N, Raghukumar G, Tsang E, & Buxton JA (2015). Why the FUSS (Fentanyl Urine Screen Study)? A cross-sectional survey to characterize an emerging threat to people who use drugs in British Columbia, Canada. Harm Reduction Journal, 12(1). 10.1186/s12954-015-0088-4 - DOI - PMC - PubMed
    1. Arfken CL, Suchanek J, & Greenwald MK (2017). Characterizing fentanyl use in methadone-maintained clients. Journal of Substance Abuse Treatment, 75, 17–21. 10.1016/j.jsat.2017.01.004 - DOI - PubMed
    1. Cicero TJ, Ellis MS, & Kasper ZA (2017). Increases in self-reported fentanyl use among a population entering drug treatment: The need for systematic surveillance of illicitly manufactured opioids. Drug and Alcohol Dependence, 177, 101–103. 10.1016/j.drugalcdep.2017.04.004 - DOI - PubMed
    1. Frank RG, & Pollack HA (2017). Addressing the fentanyl threat to public health. New England Journal of Medicine, 376(7), 605–607. - PubMed
    1. Griswold MK, Chai PR, Krotulski AJ, Friscia M, Chapman B, Boyer EW, … Babu KM (2017). Self-identification of nonpharmaceutical fentanyl exposure following heroin overdose. Clinical Toxicology, 1–6. 10.1080/15563650.2017.1339889 - DOI - PMC - PubMed

Publication types